Salvage Boron Neutron Capture Therapy for Malignant Brain Tumor Patients in Compliance with Emergency and Compassionate Use: Evaluation of 34 Cases in Taiwan

Using salvage Boron Neutron Capture Therapy (BNCT) for recurrent malignant brain tumors in Taiwan

(2020) Tien-Li Lan et al.   APPLIED RADIATION AND ISOTOPES

Boron neutron capture therapy for malignant brain tumors

(2020) Shin-Ichi Miyatake et al.   JOURNAL OF NEURO-ONCOLOGY

The importance of optimal ROIs delineation for FBPA-PET before BNCT

(2020) Yi-Wen Lo et al.   APPLIED RADIATION AND ISOTOPES

Boron neutron capture therapy: Current status and future perspectives

(2020) Mayya Alexandrovna Dymova et al.   Cancer Communications

Update on Chemotherapeutic Approaches and Management of Bevacizumab Usage for Glioblastoma

(2020) Yusuke Funakoshi et al.   Pharmaceuticals

4-Borono-2-18F-fluoro-l-phenylalanine PET for boron neutron capture therapy-oriented diagnosis: overview of a quarter century of research

(2019) Kiichi Ishiwata   ANNALS OF NUCLEAR MEDICINE

Effectiveness of lomustine and bevacizumab in progressive glioblastoma: a meta-analysis

(2018) Jie Song et al.   OncoTargets and Therapy

Boron Neutron Capture Therapy for High-Grade Skull-Base Meningioma

(2018) Koji Takeuchi et al.   Journal of Neurological Surgery Part B-Skull Base

Proposal for determining absolute biological effectiveness of boron neutron capture therapy—the effect of 10B(n,α)7Li dose can be predicted from the nucleocytoplasmic ratio or the cell size

(2018) Koji Ono et al.   JOURNAL OF RADIATION RESEARCH

Lomustine and Bevacizumab in Progressive Glioblastoma

(2017) Wolfgang Wick et al.   NEW ENGLAND JOURNAL OF MEDICINE

Preliminary dosimetric study on feasibility of multi-beam boron neutron capture therapy in patients with diffuse intrinsic pontine glioma without craniotomy

(2017) Jia-Cheng Lee et al.   PLoS One

2016 Updates to the WHO Brain Tumor Classification System: What the Radiologist Needs to Know

(2017) Derek R. Johnson et al.   RADIOGRAPHICS

Bevacizumab combined with chemotherapy for glioblastoma: a meta-analysis of randomized controlled trials

(2017) Shou-Bo Yang et al.   Oncotarget

An analysis of the structure of the compound biological effectiveness factor

(2016) Koji Ono   JOURNAL OF RADIATION RESEARCH

Boron Neutron Capture Therapy for Malignant Brain Tumors

(2016) Shin-Ichi MIYATAKE et al.   NEUROLOGIA MEDICO-CHIRURGICA

Bevacizumab for glioblastoma

(2015) Yoshitaka Narita   Therapeutics and Clinical Risk Management

Boron neutron capture therapy with bevacizumab may prolong the survival of recurrent malignant glioma patients: four cases

(2014) Shin-Ichi Miyatake et al.   Radiation Oncology

Boron neutron capture therapy outcomes for advanced or recurrent head and neck cancer

(2013) M. Suzuki et al.   JOURNAL OF RADIATION RESEARCH

Bevacizumab treatment of symptomatic pseudoprogression after boron neutron capture therapy for recurrent malignant gliomas. Report of 2 cases

(2013) Shin-Ichi Miyatake et al.   NEURO-ONCOLOGY

Boron neutron capture therapy for newly diagnosed glioblastoma multiforme: An assessment of clinical potential

(2011) J.W. Hopewell et al.   APPLIED RADIATION AND ISOTOPES

Randomized Double-Blind Placebo-Controlled Trial of Bevacizumab Therapy for Radiation Necrosis of the Central Nervous System

(2010) Victor A. Levin et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Repeated treatments with bevacizumab for recurrent radiation necrosis in patients with malignant brain tumors: a report of 2 cases

(2010) Motomasa Furuse et al.   JOURNAL OF NEURO-ONCOLOGY

Survival benefit from boron neutron capture therapy for the newly diagnosed glioblastoma patients

(2009) Shinji Kawabata et al.   APPLIED RADIATION AND ISOTOPES

Boron Neutron Capture Therapy for Newly Diagnosed Glioblastoma

(2009) Shinji KAWABATA et al.   JOURNAL OF RADIATION RESEARCH

FDA Drug Approval Summary: Bevacizumab (Avastin(R)) as Treatment of Recurrent Glioblastoma Multiforme

(2009) M. H. Cohen et al.   ONCOLOGIST

Boron neutron capture therapy for newly diagnosed glioblastoma

(2009) Tetsuya Yamamoto et al.   RADIOTHERAPY AND ONCOLOGY

Survival benefit of Boron neutron capture therapy for recurrent malignant gliomas

(2008) Shin-Ichi Miyatake et al.   JOURNAL OF NEURO-ONCOLOGY